Immunological methods for diagnosing neurocysticercosis

Patent · Tue Jan 31 00:00:00 EST 1989

OSTI ID:5896296

Kuhn, R E; Estrada, J J; Grogl, M

A method is described for diagnosing active human neurocysticercosis by detecting the presence of at least one Taenia solium larval antigen in cerebrospinal fluid, which comprises: contacting cerebrospinal fluid from a human to be diagnosed with a solid support, wherein the support binds with a Taenia solium larval antigen if present, contacting the support with a first antibody, wherein the first antibody binds with a larval Taenia solium antigen if present in the cerebrospinal fluid, contacting the solid support with a detectable second antibody which will bind with the first antibody, and detecting the second antibody bound to the support.

• Assignee: Wake Forest Univ., Winston-Salem, NC
• Patent Number(s): US 4801532
• OSTI ID: 5896296
• Resource Relation: Patent File Date: Filed date 30 Sep 1987
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
59 BASIC BIOLOGICAL SCIENCES
NERVOUS SYSTEM
IMMUNOASSAY
NERVOUS SYSTEM DISEASES
DIAGNOSIS
ANTIBODIES
ANTIGENS
BIOASSAY
CEREBROSPINAL FLUID
DETECTION
DIAGNOSTIC USES
LARVAE
MAN
ANIMALS
BIOLOGICAL MATERIALS
BODY FLUIDS
DISEASES
MAMMALS
MATERIALS
PRIMATES
USES
VERTEBRATES
550600* - Medicine
550200 - Biochemistry